medigraphic.com
ISSN 1727-897X (Electronic)

2021, Number 6

<< Back Next >>

Medisur 2021; 19 (6)

Epidemiological, clinical and imaging profile of Multiple Sclerosis

Vázquez-Gómez LA, Hidalgo MC, Beltrán GBM, Broche-Pérez Y, Mederos-Herrera AM

Language: Spanish
References: 19
Page: 948-958
PDF size: 369.27 Kb.


ABSTRACT

Background: multiple sclerosis is a neurological, autoimmune, degenerative, chronic and progressive demyelinating disease associated with different genetic and environmental factors.
Objective: to characterize epidemiologically, clinically and imaging patients with a diagnosis of multiple sclerosis.
Methods: observational, descriptive, cross-sectional study on all patients with a diagnosis of multiple sclerosis with follow-up at the Arnaldo Milián Castro Provincial University Clinical-Surgical Hospital, in Villa Clara during the period from January 2014 to December 2019. The epidemiological variables analyzed: sex, age of disease onset, skin color, place of origin; clinical variables: symptoms at the beginning and at present; number of shoots; years of evolution, clinical forms; Imaging variables: number of lesions, location, atrophy or change in signal intensity of the corpus callosum and McDonald's criterion fulfilled.
Results: there was a higher incidence of females with 80 patients. It was found that 59 patients had a relapsing-remitting clinical form, 21 patients had a secondary progressive form, 4 patients had a primary progressive and 2 patients had a relapsing progressive one. Symptoms: motor deficit, sensory deficit and cerebellar alterations were the most frequent at the beginning and at present. Disability evaluated as minimal was found in 50 patients and 31 patients had 2 to 4 lesions on nuclear magnetic resonance.
Conclusions: Adequate epidemiological information on patients with multiple sclerosis in Villa Clara was obtained satisfactorily. It is important to consider this report as a basis for decision-making on issues of projection of treatment and care, aspects of great importance in high-cost diseases, such as multiple sclerosis.


REFERENCES

  1. Bravo González F, Álvarez Roldán A. Esclerosis múltiple, pérdida de funcionalidad y género. Gac Sanit[Internet]. 2019[citado 20/05/2019];33(2):[aprox. 8 p.]. Disponible en: http://www.gacetasanitaria.org/index.php?p=revista&tipo=pdfsimple&pii=S0213911117302662

  2. Martinez MC, Ramos O, Luna IM, Arrieta E. Revisión de la esclerosis múltiple (1). A propósito de un caso. Semergen[Internet]. 2015[citado 20/05/2019];41(5):[aprox. 5 p.]. Disponible en: https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S1138359314003232&r=40

  3. Guadarrama Ortiz P, Regalado Guerra X, Castillo Rangel C, Ángeles Castellanos M. Esclerosis múltiple: enfermedad neurológica de alto impacto social. Rev Fac Med [Internet]. 2014[citado 20/05/2019];57(6):[aprox. 2 p.]. Disponible en: http://www.medigraphic.com/pdfs/facmed/un-2014/un146b.pdf

  4. Cabrera Gómez JA, Santana Capote E, Vals O, Casanova M, Alfaro I, González Quevedo A. Caracterización clínica de pacientes con esclerosis múltiple definida en Cuba. Rev Neurol[Internet]. 1998[citado 20/05/2019];26(153):[aprox. 5 p.]. Disponible en: http://www.researchgate.net/publication/13649254

  5. Fernández Fernández O, Saiz Hinarejos A. Enfermedades desmielinizantes del sistema nervioso central. En: Rozman Borstnar C, Cardellach López F. Medicina Interna[Internet]. Madrid: Elsevier; 2016. p. 1381-91. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/3-s2.0-B978849022996500171X.pdf?locale=es_ES

  6. Ropper A, Brown R. Esclerosis múltiple y enfermedades desmielinizantes relacionadas. In: Ropper A, ed. Adams y Víctor. Principios de neurología de. 8th ed. Ciudad México: McGraw-Hill Companies, Inc.; 2015. p. 771-794.

  7. López Méndez P, Sosa Henríquez M. Vitamina D y esclerosis múltiple. Prevalencia de hipovitaminosis D. Rev Osteoporos Metab Miner[Internet]. 2015[citado 20/05/2019];7(2):[aprox. 5 p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2015000200006

  8. Bradley WG, Daroff RB. Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System. En: Bradley's neurology in clinical practice. 6th ed. Philadelphia: Elsevier Inc.; 2015. p. 1283-1310.

  9. Bertado Cortés B, Villamil Osorio L, Carrera Pineda R, Martínez Cortés C, Guerrero Canter J. Características clínicas y demográficas de los pacientes con esclerosis múltiple. Rev Med Inst Mex Seguro Soc[Internet]. 2016[citado 20/05/2019];54(Sup 2):[aprox. 5 p.]. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2016/ims162j.pdf

  10. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology. [Internet]. 2018[citado 20/05/2019];17(2):62-173. Disponible en: http://discovery.ucl.ac.uk/10041020/1/Barkhof_Diagnosticcriteria_revision1_final_10OCT2017.pdf

  11. Mohammed E. Multiple sclerosis is prominent in the Gulf states: Review. Pathogenesis [Internet]. 2016[citado 20/05/2019];3:[aprox. 20 p.]. Disponible en: http://ac.els-cdn.com/S2214663616300049/1-s2.0-S2214663616300049-main.pdf?_tid=3154a542-455a-11e7-9672-00000aab0f01&acdnat=1496164113_6486264bb1d09bf35dc086211565c493

  12. Rojas E, Alva A, Montalvan V. Cambios clínicos de la esclerosis múltiple según modificación de los criterios de McDonald. Hospital Almenara, 2001-2015. An Fac Med [Internet]. 2019[citado 20/02/2020];80(1):[aprox. 14 p.] Disponible en: https:/www.scielo.org.pe/scielo.php?scrip=sci_arttext&pid=S1025-55832019000100006.

  13. Bertado-Cortés B, Villamil-Osorio L, Carrera-Pineda R, Martínez-Cortés C, Guerrero-Cantera J. Características clínicas y demográficas de los pacientes con esclerosis múltiple Revista Médica del Instituto Mexicano del Seguro Social. 2016;54(2):186-190.

  14. Gracia F, Armién B, Rivera V, Valverde A, Rodríguez V, Monterrey P, et al. Multiple Sclerosis in Central American and Spanish Caribbean Region: Should it be Recognized as a Public Health Problem?, Collaborative Multiple Sclerosis Group of Central America and Spanish Caribbean Region (CMSG). J Epid Prev Med. 2017; 3:134.

  15. Alonso R, Quarracino C, Eizaguirre B, Cohen L, Silva B, Pita C, et al. Clinical and demographic characteristic of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelavarEM). Neurol Sci. 2020;41:3329-35.

  16. Bsteh G, Ehling R, Lutterotti A, Hegen H, Di Pauli F, Auer M, Deisenhammer F, Reindl M, Berger T. Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study. PLoS One[Internet]. 2016[citado 20/02/2020];11(7):[aprox. 18 p.] Disponible en: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158978&type=printable

  17. Correa P, Ortiz A, Torres G, Buestan M, Martinez B, Paredes V, Jácome C, Vásconez V, Zambrano J, Flores E, Benalcázar E, Barros J, Acosta C. The Clinical and Epidemiological Spectrum of Multiple Sclerosis in Quito,Ecuador. J Neurol Disord[Internet]. 2016[citado 20/02/2020];4(7):[aprox. 17 p.] Disponible en: https://www.researchgate.net/publication/309876930_The_Clinical_and_Epidemiological_Spectrum_of_Multiple_Sclerosis_in_Quito_Ecuador

  18. Sellán Paniceres, C. Registro de los potenciales evocados: Aproximación a los componentes P300 y N400. Rev Psicol Gral y Aplic[Internet]. 1991[citado 20/02/2020];44(3):[aprox.6 p.] Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=2860465

  19. Pérez-Álvarez AI, García-Rúa A, Suárez-Santos P, CastañónApilánez M, Ameijide-Sanluis E, Saiz-Ayala A, et al. Valoración de la atrofia cerebral en la esclerosis múltiple mediante el índice de cuerpo calloso. Rev Neurol. 2018;67:417-24.




2020     |     www.medigraphic.com